Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0000902664-23-002771
Filing Date
2023-05-03
Accepted
2023-05-03 10:28:53
Documents
7

Document Format Files

Seq Description Document Type Size
1 EXELIXIS, INC. p23-1369defc14a.htm DEFC14A 497181
2 GRAPHIC image01.jpg GRAPHIC 62631
3 GRAPHIC image02.jpg GRAPHIC 18478
4 GRAPHIC image03.jpg GRAPHIC 45578
5 GRAPHIC image04.jpg GRAPHIC 51945
6 GRAPHIC image05.jpg GRAPHIC 1966
7 GRAPHIC image06.jpg GRAPHIC 1921
  Complete submission text file 0000902664-23-002771.txt   751188
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Subject) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A | Act: 34 | File No.: 000-30235 | Film No.: 23882189
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O FARALLON PARTNERS, L.L.C. ONE MARITIME PLAZA, SUITE 2100 SAN FRANCISCO CA 94111
Business Address C/O FARALLON PARTNERS, L.L.C. ONE MARITIME PLAZA, SUITE 2100 SAN FRANCISCO CA 94111 (415) 421-2132
Farallon Capital Partners, L.P. (Filed by) CIK: 0001175707 (see all company filings)

EIN.: 943106322 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEFC14A